- Name of company
- Seren Pharmaceuticals Inc.
- Company Foundation
- April 30th, 2010
- Nihonbashi DOLL-1 Bldg, 3rd and 4th floors (3rd floor reception),
1-2-13, Nihonbashi Ningyocho, Chuo-ku,
Tokyo, 103-0013 Japan
- Board Members
- President&CEOAkira Nakagawa
- CEODaisaku Shimoda
- Executive VPMasakazu Fukusakura
- DirectorTakahiro Aihara
- AuditorEiji Mizuta
- 92,370,000 yen (to date)
- MUFG Bank
- Mizuho Bank
3-minute walk from Exit A6 of Ningyocho Station on the Tokyo Metro Hibiya Line and Toei Asakusa Line.
- Our group of drug development specialists seeks and introduces drugs from new perspectives and promotes early development of drugs that have a low priority in development despite high market needs and are not progressing well.
- We develop drugs with strong medical needs from academic societies, etc., and contribute to eliminating the drug lag.
- We promote joint development with other companies in order to reduce the risk of drug development.